Latest stories on ROIV
Pfizer, BioNTech face global patent suits from Arbutus, Roivant over COVID vaccine tech
Seeking Alpha34 · bearishgeneral
Could Roivant Sciences Be a Multibagger Stock Over the Next 5 Years?
The Motley Fool67 · bullishanalyst
Here is Why Roivant (ROIV) is One of the Best Growth Stocks Trading in Oversold Territory
Yahoo Finance63 · neutralanalyst
Roivant Sciences Ltd. (ROIV) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
Guggenheim Remains Bullish on Roivant Sciences Ltd. (ROIV)
Yahoo Top61 · neutralanalyst
Roivant Sciences Ltd. (ROIV) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
Roivant Sciences Ltd. (ROIV) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Seeking Alpha55 · neutralgeneral
TD Cowen Raises its Price Target on Roivant Sciences (ROIV)
Yahoo Top61 · neutralanalyst
Roivant: Immunovant's Rheumatoid Arthritis Win Validates The Buy
Seeking Alpha67 · bullishproduct/pr
Roivant Sciences Ltd. 2025 Q4 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Roivant (ROIV) Climbs 15% on Swing to Profits
Yahoo Top73 · bullishearnings
Roivant anticipates $950M Moderna payment in July as it outlines 2H 2026 mosliciguat and IMVT-1402 readouts
Seeking Alpha63 · neutralproduct/pr
Roivant Sciences Ltd. (ROIV) Q4 2025 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug
Barron's73 · bullishproduct/pr
Roivant Shares Climb on Earnings Beat Despite Revenue Shortfall (ROIV)
Yahoo Top63 · neutralearnings
Roivant Highlights Strong Clinical Advancements, $2.25B Moderna Settlement, and Robust Cash Position in FY26 Update
MarketChameleon73 · bullishgeneral
Roivant Sciences Q4 2026 Earnings Preview
Seeking Alpha56 · neutralearnings
Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral